Symbols / ADGM Stock $0.75 +0.62% Adagio Medical Holdings, Inc.
ADGM (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteAdagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-06-03 | init | LUCID CAPITAL MARKETS | — → Buy | $3 |
| 2026-04-14 | init | Piper Sandler | — → Overweight | $3 |
| 2025-12-02 | init | Lake Street | — → Buy | $4 |
- Inside Blue Owl's push into Abu Dhabi, its 23rd global office - Stock Titan ue, 09 Jun 2026 12
- ADGM - Finviz ue, 26 May 2026 13
- Number of shareholders of Adagio Medical Holdings, Inc – NASDAQ:ADGM - TradingView Wed, 03 Jun 2026 20
- Adagio Medical Holdings Inc. Stock (ADGM) Opinions on Insider Purchase - Quiver Quantitative ue, 16 Dec 2025 08
- ADGM Initiates Coverage On LUCID CAPITAL MARKETS -- Rating Set t - GuruFocus hu, 04 Jun 2026 01
- Ondo Tokenized Stocks Win Abu Dhabi Approval on Binance - CoinMarketCap Sat, 06 Jun 2026 16
- Adagio Medical Holdings' US$2.5m Market Cap Fall Books Insider Losses - simplywall.st Sat, 16 May 2026 07
- Adagio Medical (ADGM) Announces Successful Results From US Cardiac Ablation Feasibility Study - Yahoo Finance ue, 24 Feb 2026 08
- Nest Trading, Operator of Binance’s US Stock Service, Officially Confirmed as Affiliate - CryptoRank Mon, 01 Jun 2026 16
- Lucid Capital Markets initiates Adagio Medical stock with buy rating By Investing.com - Investing.com South Africa Wed, 03 Jun 2026 12
- Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia - Business Wire hu, 21 May 2026 07
- Ondo Finance tokenized stocks platform on Binance wins regulatory approval in Abu Dhabi - CoinDesk ue, 03 Mar 2026 08
- 12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga Mon, 27 Apr 2026 07
- Preclinical heart catheter study points to 30 minutes less procedure time - Stock Titan ue, 24 Mar 2026 07
- symbol__ Stock Quote Price and Forecast - CNN Sat, 10 Aug 2024 19
Financials
| Line Item | Trend | 2025-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
-100.00%
|
0.30
+58.73%
|
0.19
-30.00%
|
0.27
|
| Operating Revenue |
|
0.00
-100.00%
|
0.30
+58.73%
|
0.19
-30.00%
|
0.27
|
| Cost Of Revenue |
|
0.68
-47.63%
|
1.31
+49.26%
|
0.88
-24.44%
|
1.16
|
| Reconciled Cost Of Revenue |
|
0.68
-47.63%
|
1.31
+49.26%
|
0.88
-24.44%
|
1.16
|
| Gross Profit |
|
-0.68
+32.01%
|
-1.01
-46.65%
|
-0.69
+22.75%
|
-0.89
|
| Operating Expense |
|
21.21
-21.27%
|
26.94
+15.97%
|
23.23
+17.56%
|
19.76
|
| Research And Development |
|
10.64
-30.91%
|
15.40
-13.76%
|
17.86
+16.28%
|
15.36
|
| Selling General And Administration |
|
10.57
-8.41%
|
11.54
+114.76%
|
5.37
+22.04%
|
4.40
|
| Total Expenses |
|
21.89
-22.49%
|
28.24
+17.18%
|
24.10
+15.24%
|
20.91
|
| Operating Income |
|
-21.89
+21.66%
|
-27.94
-16.85%
|
-23.91
-15.83%
|
-20.64
|
| Total Operating Income As Reported |
|
-21.89
+21.66%
|
-27.94
-16.85%
|
-23.91
-15.83%
|
-20.64
|
| EBITDA |
|
-21.21
+41.02%
|
-35.95
-56.05%
|
-23.04
-17.54%
|
-19.60
|
| Normalized EBITDA |
|
-21.23
+40.89%
|
-35.91
-55.87%
|
-23.04
-13.25%
|
-20.35
|
| Reconciled Depreciation |
|
0.97
+82.33%
|
0.53
+7.47%
|
0.49
+47.32%
|
0.34
|
| EBIT |
|
-22.18
+39.22%
|
-36.49
-55.03%
|
-23.54
-18.05%
|
-19.94
|
| Total Unusual Items |
|
0.02
+147.62%
|
-0.04
|
0.00
-100.00%
|
0.74
|
| Total Unusual Items Excluding Goodwill |
|
0.02
+147.62%
|
-0.04
|
0.00
-100.00%
|
0.74
|
| Special Income Charges |
|
0.00
+100.00%
|
-8.49
|
0.00
-100.00%
|
0.74
|
| Other Special Charges |
|
—
|
8.49
|
—
|
-0.74
|
| Impairment Of Capital Assets |
|
0.00
|
—
|
—
|
—
|
| Net Income |
|
-25.08
+34.24%
|
-38.15
-61.14%
|
-23.67
-18.73%
|
-19.94
|
| Pretax Income |
|
-25.08
+34.24%
|
-38.15
-61.14%
|
-23.67
-18.73%
|
-19.94
|
| Net Non Operating Interest Income Expense |
|
-2.43
-46.68%
|
-1.66
-1589.80%
|
-0.10
-3366.67%
|
0.00
|
| Interest Expense Non Operating |
|
2.91
+75.17%
|
1.66
+1110.95%
|
0.14
|
0.00
|
| Net Interest Income |
|
-2.43
-46.68%
|
-1.66
-1589.80%
|
-0.10
-3366.67%
|
0.00
|
| Interest Expense |
|
2.91
+75.17%
|
1.66
+1110.95%
|
0.14
|
0.00
|
| Interest Income Non Operating |
|
0.48
+15800.00%
|
0.00
-92.31%
|
0.04
+1200.00%
|
0.00
|
| Interest Income |
|
0.48
+15800.00%
|
0.00
-92.31%
|
0.04
+1200.00%
|
0.00
|
| Other Income Expense |
|
-0.77
+91.05%
|
-8.55
-2628.99%
|
0.34
-51.99%
|
0.70
|
| Other Non Operating Income Expenses |
|
-0.79
+90.77%
|
-8.51
-2616.57%
|
0.34
+945.00%
|
-0.04
|
| Gain On Sale Of Security |
|
0.02
+147.62%
|
-0.04
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-25.08
+34.24%
|
-38.15
-61.14%
|
-23.67
-18.73%
|
-19.94
|
| Net Income From Continuing Operation Net Minority Interest |
|
-25.08
+34.24%
|
-38.15
-61.14%
|
-23.67
-18.73%
|
-19.94
|
| Net Income From Continuing And Discontinued Operation |
|
-25.08
+34.24%
|
-38.15
-61.14%
|
-23.67
-18.73%
|
-19.94
|
| Net Income Continuous Operations |
|
-25.08
+34.24%
|
-38.15
-61.14%
|
-23.67
-18.73%
|
-19.94
|
| Normalized Income |
|
-25.10
+34.12%
|
-38.10
-60.96%
|
-23.67
-14.46%
|
-20.68
|
| Net Income Common Stockholders |
|
-25.08
+34.24%
|
-38.15
-61.14%
|
-23.67
-18.73%
|
-19.94
|
| Diluted EPS |
|
-1.51
+47.01%
|
-2.85
-61.14%
|
-1.77
-18.73%
|
-1.49
|
| Basic EPS |
|
-1.51
+47.01%
|
-2.85
-61.14%
|
-1.77
-18.73%
|
-1.49
|
| Basic Average Shares |
|
16.56
+23.67%
|
13.39
+0.00%
|
13.39
+0.00%
|
13.39
|
| Diluted Average Shares |
|
16.56
+23.67%
|
13.39
+0.00%
|
13.39
+0.00%
|
13.39
|
| Diluted NI Availto Com Stockholders |
|
-25.08
+34.24%
|
-38.15
-61.14%
|
-23.67
-18.73%
|
-19.94
|
| Average Dilution Earnings |
|
0.00
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
43.25
-10.72%
|
48.45
+609.86%
|
6.83
-21.52%
|
8.70
|
| Current Assets |
|
20.08
-20.78%
|
25.35
+388.89%
|
5.18
-22.98%
|
6.73
|
| Cash Cash Equivalents And Short Term Investments |
|
17.11
-16.91%
|
20.59
+1388.50%
|
1.38
-75.07%
|
5.55
|
| Cash And Cash Equivalents |
|
17.11
-16.91%
|
20.59
+1388.50%
|
1.38
-75.07%
|
5.55
|
| Receivables |
|
0.00
-100.00%
|
0.04
-50.70%
|
0.07
|
0.00
|
| Accounts Receivable |
|
0.00
-100.00%
|
0.04
-50.70%
|
0.07
|
0.00
|
| Inventory |
|
1.67
-34.84%
|
2.57
-22.76%
|
3.32
+805.18%
|
0.37
|
| Raw Materials |
|
1.42
-15.45%
|
1.68
-23.88%
|
2.21
|
0.00
|
| Work In Process |
|
0.16
-57.99%
|
0.39
+96.95%
|
0.20
|
0.00
|
| Finished Goods |
|
0.09
-82.63%
|
0.49
-45.84%
|
0.91
+149.05%
|
0.37
|
| Prepaid Assets |
|
0.99
-49.02%
|
1.94
+736.21%
|
0.23
-20.27%
|
0.29
|
| Other Current Assets |
|
0.32
+42.34%
|
0.22
+25.42%
|
0.18
-66.41%
|
0.53
|
| Total Non Current Assets |
|
23.17
+0.31%
|
23.10
+1308.48%
|
1.64
-16.54%
|
1.97
|
| Net PPE |
|
2.23
+3.86%
|
2.15
+32.90%
|
1.62
-16.61%
|
1.94
|
| Gross PPE |
|
4.88
+0.04%
|
4.88
+43.75%
|
3.39
+6.76%
|
3.18
|
| Accumulated Depreciation |
|
-2.65
+2.97%
|
-2.73
-53.63%
|
-1.78
-43.31%
|
-1.24
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
1.39
+38.72%
|
1.00
-4.84%
|
1.05
+7.78%
|
0.98
|
| Construction In Progress |
|
—
|
0.00
-100.00%
|
0.05
+0.00%
|
0.05
|
| Other Properties |
|
3.19
-10.53%
|
3.57
+80.17%
|
1.98
+7.43%
|
1.84
|
| Leases |
|
0.30
-3.27%
|
0.31
+0.33%
|
0.30
+0.66%
|
0.30
|
| Goodwill And Other Intangible Assets |
|
20.94
+0.00%
|
20.94
|
0.00
|
—
|
| Goodwill |
|
13.97
+0.00%
|
13.97
|
0.00
|
—
|
| Other Intangible Assets |
|
6.97
+0.00%
|
6.97
|
—
|
—
|
| Other Non Current Assets |
|
0.00
-78.57%
|
0.01
-39.13%
|
0.02
-11.54%
|
0.03
|
| Total Liabilities Net Minority Interest |
|
30.85
+8.11%
|
28.54
-79.45%
|
138.85
+32.77%
|
104.57
|
| Current Liabilities |
|
8.23
+6.05%
|
7.76
-83.54%
|
47.18
+263.79%
|
12.97
|
| Payables And Accrued Expenses |
|
6.54
+30.95%
|
5.00
-31.80%
|
7.33
+252.99%
|
2.08
|
| Payables |
|
1.08
-61.90%
|
2.84
-25.85%
|
3.83
+278.83%
|
1.01
|
| Accounts Payable |
|
1.08
-61.90%
|
2.84
-25.85%
|
3.83
+278.83%
|
1.01
|
| Current Accrued Expenses |
|
5.46
+153.15%
|
2.16
-38.31%
|
3.50
+228.45%
|
1.06
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
1.53
-41.53%
|
2.62
+67.43%
|
1.57
+27.42%
|
1.23
|
| Current Debt And Capital Lease Obligation |
|
0.15
+8.39%
|
0.14
-99.63%
|
38.20
+295.36%
|
9.66
|
| Current Debt |
|
—
|
—
|
38.12
+301.32%
|
9.50
|
| Other Current Borrowings |
|
—
|
—
|
38.12
+301.32%
|
9.50
|
| Current Capital Lease Obligation |
|
0.15
+8.39%
|
0.14
+81.01%
|
0.08
-51.53%
|
0.16
|
| Other Current Liabilities |
|
—
|
—
|
0.08
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
22.62
+8.88%
|
20.77
-77.34%
|
91.67
+0.07%
|
91.61
|
| Long Term Debt And Capital Lease Obligation |
|
21.60
+34.00%
|
16.12
+8167.69%
|
0.20
+45.52%
|
0.13
|
| Long Term Debt |
|
21.04
+30.88%
|
16.08
+11141.96%
|
0.14
|
—
|
| Long Term Capital Lease Obligation |
|
0.56
+1123.91%
|
0.05
-11.54%
|
0.05
-61.19%
|
0.13
|
| Non Current Deferred Liabilities |
|
0.88
+0.00%
|
0.88
|
0.00
|
—
|
| Non Current Deferred Taxes Liabilities |
|
0.88
+0.00%
|
0.88
|
0.00
|
—
|
| Other Non Current Liabilities |
|
—
|
3.62
+45100.00%
|
0.01
+166.67%
|
0.00
|
| Preferred Securities Outside Stock Equity |
|
—
|
0.00
-100.00%
|
91.47
+0.00%
|
91.47
|
| Stockholders Equity |
|
12.40
-37.72%
|
19.91
+115.08%
|
-132.02
-37.70%
|
-95.88
|
| Common Stock Equity |
|
12.40
-37.72%
|
19.91
+115.08%
|
-132.02
-37.70%
|
-95.88
|
| Capital Stock |
|
0.00
+0.00%
|
0.00
+100.00%
|
0.00
+0.00%
|
0.00
|
| Common Stock |
|
0.00
+0.00%
|
0.00
+100.00%
|
0.00
+0.00%
|
0.00
|
| Share Issued |
|
22.21
+46.14%
|
15.20
+4.56%
|
14.54
+8.57%
|
13.39
|
| Ordinary Shares Number |
|
22.21
+46.14%
|
15.20
+4.56%
|
14.54
+8.57%
|
13.39
|
| Additional Paid In Capital |
|
108.11
+19.46%
|
90.50
+5527.80%
|
1.61
+39.46%
|
1.15
|
| Retained Earnings |
|
-95.61
-35.45%
|
-70.59
+47.19%
|
-133.65
-37.70%
|
-97.06
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.10
-10000.00%
|
0.00
-94.12%
|
0.02
-39.29%
|
0.03
|
| Other Equity Adjustments |
|
-0.10
-10000.00%
|
0.00
-94.12%
|
0.02
-39.29%
|
0.03
|
| Total Equity Gross Minority Interest |
|
12.40
-37.72%
|
19.91
+115.08%
|
-132.02
-37.70%
|
-95.88
|
| Total Capitalization |
|
33.44
-7.07%
|
35.99
+127.29%
|
-131.88
-37.55%
|
-95.88
|
| Working Capital |
|
11.85
-32.62%
|
17.59
+141.88%
|
-41.99
-573.36%
|
-6.24
|
| Invested Capital |
|
33.44
-7.07%
|
35.99
+138.39%
|
-93.75
-8.54%
|
-86.38
|
| Total Debt |
|
21.76
+33.77%
|
16.27
-57.64%
|
38.40
+291.95%
|
9.80
|
| Net Debt |
|
3.94
|
—
|
36.88
+833.09%
|
3.95
|
| Capital Lease Obligations |
|
0.72
+279.89%
|
0.19
+44.27%
|
0.13
-55.89%
|
0.30
|
| Net Tangible Assets |
|
-8.53
-733.40%
|
-1.02
+99.22%
|
-132.02
-37.70%
|
-95.88
|
| Tangible Book Value |
|
-8.53
-733.40%
|
-1.02
+99.22%
|
-132.02
-37.70%
|
-95.88
|
| Derivative Product Liabilities |
|
0.13
-13.16%
|
0.15
|
0.00
|
—
|
| Line Item | Trend | 2025-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-19.01
+25.88%
|
-25.65
-14.46%
|
-22.41
-16.08%
|
-19.31
|
| Cash Flow From Continuing Operating Activities |
|
-19.01
+25.88%
|
-25.65
-14.46%
|
-22.41
-16.08%
|
-19.31
|
| Net Income From Continuing Operations |
|
-25.08
+34.24%
|
-38.15
-61.14%
|
-23.67
-18.73%
|
-19.94
|
| Depreciation Amortization Depletion |
|
0.97
+82.33%
|
0.53
+7.47%
|
0.49
+47.32%
|
0.34
|
| Depreciation And Amortization |
|
0.97
+82.33%
|
0.53
+7.47%
|
0.49
+47.32%
|
0.34
|
| Other Non Cash Items |
|
0.98
-88.68%
|
8.66
+5791.84%
|
0.15
|
—
|
| Stock Based Compensation |
|
1.48
+234.62%
|
0.44
+21.10%
|
0.36
+7.67%
|
0.34
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
0.03
+132.89%
|
-0.08
-162.81%
|
0.12
|
| Operating Gains Losses |
|
-0.02
-144.44%
|
0.04
|
—
|
-0.74
|
| Gain Loss On Investment Securities |
|
-0.02
-147.62%
|
0.04
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.00
|
0.00
|
—
|
| Change In Working Capital |
|
2.66
-4.59%
|
2.79
+745.15%
|
0.33
-43.01%
|
0.58
|
| Change In Receivables |
|
0.04
+154.29%
|
-0.07
-312.12%
|
0.03
-17.50%
|
0.04
|
| Changes In Account Receivables |
|
0.04
+154.29%
|
-0.07
-312.12%
|
0.03
-17.50%
|
0.04
|
| Change In Inventory |
|
0.93
+131.28%
|
-2.98
-8602.86%
|
0.04
+107.40%
|
-0.47
|
| Change In Prepaid Assets |
|
0.87
+111.46%
|
0.41
+228.13%
|
-0.32
-627.27%
|
-0.04
|
| Change In Payables And Accrued Expense |
|
4.42
-20.86%
|
5.59
+665.21%
|
0.73
-31.84%
|
1.07
|
| Change In Accrued Expense |
|
6.18
+123.40%
|
2.77
+840.48%
|
0.29
-62.88%
|
0.79
|
| Change In Payable |
|
-1.76
-162.25%
|
2.82
+547.02%
|
0.44
+56.27%
|
0.28
|
| Change In Account Payable |
|
-1.76
-162.25%
|
2.82
+547.02%
|
0.44
+56.27%
|
0.28
|
| Change In Other Current Liabilities |
|
-3.60
-2133.54%
|
-0.16
-8.78%
|
-0.15
-886.67%
|
-0.01
|
| Investing Cash Flow |
|
-0.37
-10.00%
|
-0.34
+32.00%
|
-0.50
+60.69%
|
-1.27
|
| Cash Flow From Continuing Investing Activities |
|
-0.37
-10.00%
|
-0.34
+32.00%
|
-0.50
+60.69%
|
-1.27
|
| Net PPE Purchase And Sale |
|
-0.37
-12.31%
|
-0.33
+32.04%
|
-0.49
+61.05%
|
-1.26
|
| Purchase Of PPE |
|
-0.37
-12.31%
|
-0.33
+32.32%
|
-0.49
+60.89%
|
-1.26
|
| Sale Of PPE |
|
—
|
0.00
-100.00%
|
0.00
|
0.00
|
| Capital Expenditure |
|
-0.37
-10.00%
|
-0.34
+32.27%
|
-0.50
+60.53%
|
-1.27
|
| Net Intangibles Purchase And Sale |
|
—
|
-0.01
+30.00%
|
-0.01
+28.57%
|
-0.01
|
| Purchase Of Intangibles |
|
—
|
-0.01
+30.00%
|
-0.01
+28.57%
|
-0.01
|
| Financing Cash Flow |
|
16.13
-26.24%
|
21.88
+129.66%
|
9.53
+7226.92%
|
0.13
|
| Cash Flow From Continuing Financing Activities |
|
16.13
-26.24%
|
21.88
+129.66%
|
9.53
+7226.92%
|
0.13
|
| Net Issuance Payments Of Debt |
|
0.00
-100.00%
|
21.86
+130.07%
|
9.50
|
0.00
|
| Issuance Of Debt |
|
0.00
-100.00%
|
23.00
+142.11%
|
9.50
|
0.00
|
| Repayment Of Debt |
|
0.00
+100.00%
|
-1.14
|
0.00
|
—
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
23.00
+142.11%
|
9.50
|
0.00
|
| Long Term Debt Payments |
|
0.00
+100.00%
|
-1.14
|
0.00
|
—
|
| Net Long Term Debt Issuance |
|
0.00
-100.00%
|
21.86
+130.07%
|
9.50
|
0.00
|
| Short Term Debt Issuance |
|
—
|
20.00
+110.53%
|
9.50
|
0.00
|
| Net Short Term Debt Issuance |
|
—
|
20.00
+110.53%
|
9.50
|
0.00
|
| Net Common Stock Issuance |
|
16.13
|
—
|
—
|
—
|
| Proceeds From Stock Option Exercised |
|
—
|
0.02
-28.00%
|
0.03
-80.77%
|
0.13
|
| Changes In Cash |
|
-3.25
+20.96%
|
-4.12
+69.25%
|
-13.39
+34.53%
|
-20.45
|
| Effect Of Exchange Rate Changes |
|
-0.23
-382.98%
|
-0.05
-158.02%
|
0.08
+17.39%
|
0.07
|
| Beginning Cash Position |
|
20.59
+271.12%
|
5.55
-70.58%
|
18.85
-51.95%
|
39.23
|
| End Cash Position |
|
17.11
+1136.80%
|
1.38
-75.07%
|
5.55
-70.58%
|
18.85
|
| Free Cash Flow |
|
-19.39
+25.41%
|
-25.99
-13.43%
|
-22.91
-11.35%
|
-20.58
|
| Interest Paid Supplemental Data |
|
0.00
-100.00%
|
0.21
|
0.00
|
—
|
| Common Stock Issuance |
|
16.13
|
—
|
—
|
—
|
| Issuance Of Capital Stock |
|
16.13
|
—
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-05-21 View
- 10-Q2026-05-12 View
- 8-K2026-05-12 View
- 8-K2026-04-27 View
- 8-K2026-04-20 View
- 8-K2026-04-08 View
- 10-K2026-03-27 View
- 8-K2026-03-27 View
- 42026-03-09 View
- 42026-03-09 View
- 42025-12-18 View
- 8-K2025-12-16 View
- 42025-12-15 View
- 42025-12-11 View
- 8-K2025-12-11 View
- 10-Q2025-11-12 View
- 8-K2025-11-12 View
- 8-K2025-10-24 View
- 42025-10-22 View
- 8-K2025-10-20 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|